T2EVOLVE to be present at 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients

T2EVOLVE partners Ulrich Jäger and Marie José Kersten will chair the European School of Haematology (ESH) meeting: 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients.

Abstract submission is open until 16 July.

For more information about the meeting, see the ESH website:
https://www.esh.org/conference/2nd-how-i-manage-car-t-therapies-and-bispecific-antibodies-for-my-patients/